Edition:
United States

Phibro Animal Health Corp (PAHC.OQ)

PAHC.OQ on NASDAQ Stock Exchange Global Market

34.80USD
17 Nov 2017
Change (% chg)

$-0.05 (-0.14%)
Prev Close
$34.85
Open
$34.65
Day's High
$35.00
Day's Low
$34.55
Volume
15,231
Avg. Vol
36,442
52-wk High
$40.25
52-wk Low
$26.15

Latest Key Developments (Source: Significant Developments)

Phibro Animal Health Corp posts Q3 ‍adj. EPS $0.38​​
Monday, 6 Nov 2017 04:15pm EST 

Nov 6 (Reuters) - Phibro Animal Health Corp :Phibro Animal Health Corp - qtrly ‍net sales of $193 million, an increase of $5 million, or 3 pct​.Phibro Animal Health Corp - qtrly ‍diluted EPS of $0.39​.Phibro Animal Health Corp - qtrly ‍adjusted diluted EPS of $0.38​.Q1 earnings per share view $0.37, revenue view $189.9 million -- Thomson Reuters I/B/E/S.Phibro Animal Health Corp - ‍reaffirmed financial guidance for fiscal year 2018 as initially presented in August 30, 2017 press release​.  Full Article

Phibro Animal Health Corp to acquire Biotay S.A. in Argentina
Monday, 11 Sep 2017 04:35pm EDT 

Sept 12 (Reuters) - Phibro Animal Health Corp :Phibro Animal Health Corporation to acquire Biotay S.A. in Argentina.Phibro Animal Health Corp - ‍Financial terms of transaction were not disclosed.​.Phibro Animal Health Corp - ‍Financial terms of transaction were not disclosed.​.Phibro Animal Health Corp - ‍Announced purchase of Biotay S.A., a privately held manufacturer of animal health and nutritional products in Argentina​.  Full Article

Phibro Animal Health qtrly ‍adjusted diluted EPS of $0.39​​
Wednesday, 30 Aug 2017 04:15pm EDT 

Aug 30 (Reuters) - Phibro Animal Health Corp :Qtrly ‍net sales of $195 million, an increase of $6 million, or 3%​.Qtrly ‍diluted EPS of $0.38​.Qtrly ‍adjusted diluted EPS of $0.39​.Sees FY 2018 sales $765 million to $790 million.Phibro Animal Health Corp sees ‍FY adjusted diluted EPS of $1.55 - $1.61​.Phibro Animal Health Corp - ‍capital expenditures are expected to be approximately $28 million for FY​.Phibro Animal Health - ‍expect adjusted EBITDA for qtrs ending Sept 30, Dec 31, will be approximately equal with comparable quarter for previous fiscal year​.Phibro Animal Health Corp - ‍expect growth in adjusted EBITDA primarily will occur in second half of fiscal year​.FY2017 earnings per share view $1.45 -- Thomson Reuters I/B/E/S.FY2017 revenue view $760.9 million -- Thomson Reuters I/B/E/S.  Full Article

Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro's poultry vaccine technologies
Wednesday, 5 Jul 2017 08:15am EDT 

July 5 (Reuters) - Phibro Animal Health Corp ::Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro's poultry vaccine technologies.Phibro Animal Health - to enter into long-term arrangement to license Phibro's poultry vaccine technologies to new vaccine manufacturing facility to be built by Zydus Cadila.  Full Article

Phibro Animal Health, on June 29, 2017 co, units entered into credit agreement
Thursday, 29 Jun 2017 05:43pm EDT 

June 29 (Reuters) - Phibro Animal Health Corp ::Phibro Animal Health Corp - on June 29, 2017 co, units entered into a credit agreement - sec filing.Phibro animal health -under credit agreement, lenders agreed to extend credit to co in form of term a loans in principal amount equal to $250 million.Phibro Animal Health Corp - credit facilities replaced company s previous revolving credit facility and term b loan.Phibro Animal Health - under credit agreement lenders agreed to extend credit to co in form of revolving credit facility in principal amount of $250 million.Phibro animal health corp says credit facilities mature on june 29, 2022.Phibro Animal - expects consolidated statements of operations for 3 months, year ending June 30, 2017, to include loss on extinguishment of debt of about $2.5 million.Phibro Animal Health Corp - a loss on extinguishment of debt of approximately $2.5 million, is in connection with repayment of previous credit facilities.  Full Article

Phibro Animal Health reports Q3 earnings per share $0.59
Monday, 8 May 2017 04:15pm EDT 

May 8 (Reuters) - Phibro Animal Health Corp :Q3 earnings per share $0.59.Q3 sales rose 3 percent to $190 million.Q3 adjusted earnings per share $0.37.Q3 earnings per share view $0.34, revenue view $186.7 million -- Thomson Reuters I/B/E/S.  Full Article

Ridgeworth Capital Management reports a 6.57 pct passive stake in Phibro Animal Health
Tuesday, 7 Feb 2017 08:58am EST 

Phibro Animal Health Corp :Ridgeworth Capital Management Llc reports a 6.57 percent passive stake in Phibro Animal Health Corp as of Dec 31, 2016- sec filing.  Full Article

Phibro Animal Health Corporation Q2 diluted earnings per share $0.34
Monday, 6 Feb 2017 04:15pm EST 

Phibro Animal Health Corp : Phibro Animal Health Corporation reports second quarter . Phibro Animal Health Corp qtrly diluted earnings per share $0.34 . Phibro Animal Health Corporation qtrly adjusted diluted earnings per share $0.39 . Phibro Animal Health Corporation qtrly net sales of $192 million, equal to prior year . Phibro Animal Health Corporation says have reaffirmed financial guidance for fiscal year 2017 .Q2 earnings per share view $0.35, revenue view $192.9 million -- Thomson Reuters I/B/E/S.  Full Article

Phibro Q4 earnings per share $0.38
Monday, 29 Aug 2016 04:40pm EDT 

Phibro Animal Health Corp : Q4 earnings per share $0.38 . Quarterly net sales of $189 million, an increase of 2 percent . Sees FY 2017 net sales of $750 million to $770 million . Sees FY 2017 adjusted diluted eps of $1.38 - $1.45 . Quarterly adjusted diluted EPS of $0.40 . Capital expenditures are expected to be about $30 million in FY 2017 . Expect operating margins to expand to about 15.5 percent for year 2017 . FY2017 revenue view $768.4 million -- Thomson Reuters I/B/E/S .Q4 earnings per share view $0.38, revenue view $183.6 million -- Thomson Reuters I/B/E/S.  Full Article

Phibro Animal Health submits studies reaffirming safety of Mecadox
Monday, 11 Jul 2016 04:55pm EDT 

Phibro Animal Health Corp : Phibro animal health corporation submits studies reaffirming safety of Mecadox® .During studies no carcinogenic Carbadox-derived residues were detected in meat from animals treated, as directed, with Carbadox.  Full Article

BRIEF-Phibro Animal Health Corp posts Q3 ‍adj. EPS $0.38​​

* Phibro Animal Health Corp - qtrly ‍net sales of $193 million, an increase of $5 million, or 3 pct​